ARCA Biopharma Inc (ABIO) Financials

$2.48

$-27.52 (-91.73%)

As on 30-Aug-2024 19:22EDT

Market cap

$35 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	0.18	--	--	--	--	--
Cost of Revenue	0.08	0.11	0.11	0.09	0.09	0.09
Gross Profit	0.09	-0.11	-0.11	-0.09	-0.09	-0.09
Operating Expenses	8.73	7.30	10.60	19.34	9.77	5.81
Operating Profit (EBIT)	-8.76	-7.30	-10.60	-19.34	-9.77	-5.81
Other Income	--	--	--	--	0.03	0.17
Profit before Tax	-7.20	-5.34	-9.93	-19.32	-9.75	-5.65
Provision for Tax	0.95	-0.11	-0.67	-0.09	-0.01	-0.17
Profit after Tax (Net Income)	-7.20	-5.34	-9.26	-19.23	-9.74	-5.48
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-1.42	--	-9.93	-19.32	-9.74	-5.48

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	32.57	37.02	41.67	51.04	46.52	7.61
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.20	0.28	0.38	0.41	0.42
Current Liabilities	1.27	0.64	1.13	3.50	3.50	0.93
Total Liabilities	35.12	37.86	43.09	54.92	50.43	8.54

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.02	0.27	0.39	0.50	0.46	0.06
Current Assets	33.82	37.59	42.70	54.42	49.97	8.48
Total Assets	35.12	37.86	43.09	54.92	50.43	8.54
Total Debt*	0.02	0.28	0.28	0.38	0.41	0.03
Net Current Assets	32.55	36.96	41.57	50.92	46.47	7.55

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-5.01	-10.91	-18.76	-7.73	-4.80
Cash Flow from Investing Activities	--	--	0.00	-0.04	-0.02	0.00
Cash from Financing Activities	--	--	--	23.09	48.45	6.56
Net Cash Inflow / Outflow	--	--	--	--	40.71	1.76

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-13.47	-19.82	-39.10	-35.69	-80.22
ROE (%)	-20.69	-13.57	-19.97	-39.42	-35.98	-80.37
ROA (%)	-18.51	-13.19	-18.89	-36.51	-33.03	-71.38
EBIT Margin (%)	-4,994.89	--	--	--	--	--
Net Margin (%)	-4,090.91	--	--	--	-34,778.57	-3,187.21
Cash Profit Margin (%)	-0.05	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-11.31	31.14	45.42	-97.47	-69.09	26.92
Net Profit Growth (%)	-51.01	42.32	51.87	-97.48	-77.64	30.88
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	1.07	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.36	5.09	4.02	2.74	5.00	1.50
Close Price ($)	45.96	20.40	28.44	25.80	48.12	68.53
High Price ($)	53.88	32.40	31.08	66.00	264.00	245.40
Low Price ($)	18.72	19.38	20.52	25.68	26.52	58.68
Market Cap ($ Cr)	34.82	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.01	0.01	0.01	0.01	0.00
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	26.61	59.01	37.72	15.56	14.28	9.16
Quick Ratio	26.61	--	--	--	--	--
Interest Coverage	-15.00	--	-15.70	-1,493.31	-1,092.33	-830.57

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	1,145.11	2,324.46	5,799.85	4,302.49	1,329.67
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.